MAPKAPK2 and cancer: Furthermore, p38, MK2, and phospho-MK2 are markedly upregulated in primary tumors of various cancers and exhibit an inverse correlation with overall survival rates (Berggren et al., 2019; Kudaravalli et al., 2022; Morgan et al., 2022; Pomérance et al., 2006; Suresh et al., 2023).